PapersPMID:30036516
Impact of Potassium Citrate vs Citric Acid on Urinary Stone Risk in Calcium Phosphate Stone Formers.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →“H3Cit did not significantly alter citraturia, calciuria, pH, or ammonium compared with placebo (and Table 2).”
- Study
- crossover
- Duration
- 7 days
- Dose studied
- citric acid (H3Cit) tablets, 30 mEq twice daily (60 mEq per day) with breakfast and dinner, versus matching placebo
- Population
- 13 recurrent calcium phosphate stone formers without hypercalciuria, on a fixed metabolic diet in all phases
Study record
- Design
- crossover trial
- Species
- human
- Population
- recurrent calcium phosphate stone formers without hypercalciuria
- Participants
- 13
- Comparator
- placebo
- Duration
- 7 days
- Endpoints measured
- 20